Cookie Img
 
 
Hotline Numbers:
+91 9289151047, +91 9811437895
 
 
Home » Products » Project Report on Pharmaceuticals Technology » Project Report on Bulk Drugs [Eiri-1495]

Project Report on Bulk Drugs [Eiri-1495]

Project Report on Bulk Drugs [Eiri-1495]
Project Report on Bulk Drugs [Eiri-1495]
Product Code : Project Report
Brand Name : ITI
Product Description
Bulk Drugs [Eiri-1495]

A bulk drug also called active pharmaceutical ingredient (API) is the chemical molecule in a pharmaceutical product (medicines we buy from the chemist) that lends the product the claimed therapeutic effect. In other words, it is the substance responsible for the product being a medicine, penicillin to give one example. As is evident from this, there are ingredients other than the API in products sold as medicines. These inactive ingredients - excipients may or may not change from product to product, while the bulk drug would inevitably remain the same as it is the identity of the medicine. When the bulk drug is absent, the product is no longer a medicine and when it is changed, it is a new medicine. One may ask if the existence of the inactive ingredients signify anything to the patient. In the case of most of the existing bulk drugs, change of inactive ingredients don't impact the curative quality of the product, although there are exceptions. This means the drug manufacturers more or less have the liberty to "formulate" the bulk drug using excipents of his choice depending on chemical feasibility and commercial interests. The medicines in the markets in the "form" of tablets, capsules, syrups, drops, intravenous fluids etc., are therefore "formulations." In plain language, the products we refer to as medicines are formulations (of bulk drugs) and not bulk drugs per se.

Cost Estimation

Plant Capacity                            1333.33 KGS/Day
Land & Building (3570 sq.mt.)    Rs. 3.88 Cr.
Plant & Machinery                      Rs. 5.32 Cr.        
W.C. for 3 Months                      Rs. 5.58 Cr.          
Total Capital Investment               Rs. 15.38 Cr.             
Rate of Return                             64%  
Break Even Point                         40%

Note: ITI can modify the Capacity and Project Cost based on your requirement.

Contents of the Project Reports

Introduction
Uses and Applications
Properties
Market Position
Present Manufacturers
Detailed Process of Manufacture
Formulations
B.I.S. Specifications
Process Flow Sheet Diagram, Plant Layout,
Cost Economics with Profitability Analysis
Capacity
Land & Building Requirements with Rates
List & Details of Plant and Machinery with their Costs
Raw Materials Details/List and Costs
Power & Water Requirements
Labour/Staff Requirements
Utilities and Overheads
Total Capital Investment
Turnover
Cost of Production
Break Even Point
Profitability
Land Man Ratio
Suppliers of Plant & Machineries and Raw Materials
Cash Flow Statement
Repayment Schedule
Interest Chart
Depreciation Chart
Projected Balance Sheet for 5 Years etc.

Industrial Technologies, India

Contact Us

( *represents compulsory fields )

Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



 
Industrial Technologies, India
4449, Nai Sarak, Main Road, Delhi - 110006, India
Phone : +919206073529
Mr. Ankur Gupta (CEO)
Mobile : +919206073529
indltech@hotmail.com
 
 
 
Account Holder Name: Industrial Technologies, India IFSC/NEFT/RTGS Code : SBIN0001273
Current Account Number: 3312 1123 908 MICR CODE : 110002141
Bank Address: State Bank of India, Hauz Quazi, Delhi 110006, India
 
INDUSTRIAL TECHNOLOGIES, INDIA All Rights Reserved.